Minimal change nephrotic syndrome with Guillain-Barré syndrome

Mohammad Ilyas1, Asad Tolaymat

  • 1Department of Pediatric Nephrology, University of Florida/Jacksonville, 820 Prudential Drive, Suite 405, Jacksonville, FL 32207, USA. mohammad.ilyas@jax.ufl.edu

Insights

Guillain-Barré syndrome (GBS) can trigger minimal change nephrotic syndrome (MCNS) in adolescents. This rare association in a pediatric patient responded well to steroid treatment, highlighting a novel clinical link.

Area of Science:

  • Pediatric Nephrology
  • Neurology
  • Immunology

Background:

  • Guillain-Barré syndrome (GBS) is an autoimmune disorder affecting the peripheral nervous system.
  • Minimal Change Nephrotic Syndrome (MCNS) is a common cause of nephrotic syndrome in children, characterized by normal glomeruli on light microscopy.
  • The co-occurrence of GBS and MCNS is exceptionally rare, particularly in the pediatric population.

Observation:

  • A 17-year-old male diagnosed with GBS subsequently presented with severe proteinuria and edema.
  • Renal biopsy confirmed the diagnosis of MCNS in the patient.
  • This clinical presentation represents a potential paraneoplastic or post-infectious complication of GBS.

Findings:

  • The study reports the first known case of ex novo MCNS associated with GBS in a pediatric patient.
  • The nephrotic syndrome (NS) in this patient demonstrated a positive response to corticosteroid therapy.
  • This case suggests a possible shared immunological pathway or trigger between GBS and MCNS.

Implications:

  • This association broadens the understanding of potential renal manifestations of GBS.
  • It highlights the importance of considering MCNS in pediatric patients presenting with nephrotic symptoms following GBS diagnosis.
  • Further research may elucidate the underlying mechanisms linking these two conditions and inform treatment strategies.